drugset
drugset / Trial / NCT04501640

A Study to Investigate the Effect of Food With Mirabegron in Healthy Chinese Participants

NCT04501640 ↗

Phase 4 Completed 24 enrolled Astellas Pharma Inc
RandomizedCrossoverOpen-labelBasic science

Summary

This study determined the effect of food on the pharmacokinetics (PK) of single oral doses of mirabegron in healthy Chinese male and female participants. This study also evaluated the safety and tolerability of single oral doses of mirabegron in healthy Chinese male and female participants.

Timeline

Start
2020-09-21
Primary completion
2020-10-14
Completion
2020-10-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Mirabegron Other / unclassified 25 mg Oral
Subject Mirabegron Other / unclassified 50 mg Oral

Indications

No indication recorded.